Fractyl Health closes $20.7M underwritten offering of common stock and warrants

FRACTYL HEALTH, INC.

Issued 19,047,619 shares and warrants to buy up to 38,095,238 shares at combined price of $1.05/unit.
Net proceeds of ~$20.7M; funds to support Revita and Rejuva pipeline programs and working capital.
Tranche A warrants exercisable at $1.05, 2-year term; callable after REMAIN-1 data if stock >$1.37 for 15 days.
Tranche B warrants require stockholder approval, 5-year term; directors, officers, Mithril agreed to vote in favor.
Underwriter exercised full over-allotment for additional 2,857,142 units, increasing total offering size.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.